[Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].
Takahashi
Yuko
Y
Division of Rheumatic Diseases, International Medical Center of Japan, Tokyo.
Ochi
Hisako
H
Yanai
Atsushi
A
Yamashita
Hiroyuki
H
Itoh
Kenji
K
Mimori
Akio
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D008875:Middle Aged; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C502936:tocilizumab